Wang Limin, Gao Pei, Zhang Mei, Huang Zhengjing, Zhang Dudan, Deng Qian, Li Yichong, Zhao Zhenping, Qin Xueying, Jin Danyao, Zhou Maigeng, Tang Xun, Hu Yonghua, Wang Linhong
National Center for Chronic and Non-communicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China.
Department of Epidemiology and Biostatistics, School of Public Health, Peking University, Beijing, China.
JAMA. 2017 Jun 27;317(24):2515-2523. doi: 10.1001/jama.2017.7596.
Previous studies have shown increasing prevalence of diabetes in China, which now has the world's largest diabetes epidemic.
To estimate the recent prevalence and to investigate the ethnic variation of diabetes and prediabetes in the Chinese adult population.
DESIGN, SETTING, AND PARTICIPANTS: A nationally representative cross-sectional survey in 2013 in mainland China, which consisted of 170 287 participants.
Fasting plasma glucose and hemoglobin A1c levels were measured for all participants. A 2-hour oral glucose tolerance test was conducted for all participants without diagnosed diabetes.
Primary outcomes were total diabetes and prediabetes defined according to the 2010 American Diabetes Association criteria. Awareness and treatment were also evaluated. Hemoglobin A1c concentration of less than 7.0% among treated diabetes patients was considered adequate glycemic control. Minority ethnic groups in China with at least 1000 participants (Tibetan, Zhuang, Manchu, Uyghur, and Muslim) were compared with Han participants.
Among the Chinese adult population, the estimated standardized prevalence of total diagnosed and undiagnosed diabetes was 10.9% (95% CI, 10.4%-11.5%); that of diagnosed diabetes, 4.0% (95% CI, 3.6%-4.3%); and that of prediabetes, 35.7% (95% CI, 34.1%-37.4%). Among persons with diabetes, 36.5% (95% CI, 34.3%-38.6%) were aware of their diagnosis and 32.2% (95% CI, 30.1%-34.2%) were treated; 49.2% (95% CI, 46.9%-51.5%) of patients treated had adequate glycemic control. Tibetan and Muslim Chinese had significantly lower crude prevalence of diabetes than Han participants (14.7% [95% CI, 14.6%-14.9%] for Han, 4.3% [95% CI, 3.5%-5.0%] for Tibetan, and 10.6% [95% CI, 9.3%-11.9%] for Muslim; P < .001 for Tibetan and Muslim compared with Han). In the multivariable logistic models, the adjusted odds ratios compared with Han participants were 0.42 (95% CI, 0.35-0.50) for diabetes and 0.77 (95% CI, 0.71-0.84) for prediabetes for Tibetan Chinese and 0.73 (95% CI, 0.63-0.85) for diabetes and 0.78 (95% CI, 0.71-0.86) for prediabetes in Muslim Chinese.
Among adults in China, the estimated overall prevalence of diabetes was 10.9%, and that for prediabetes was 35.7%. Differences from previous estimates for 2010 may be due to an alternate method of measuring hemoglobin A1c.
以往研究表明,中国糖尿病患病率不断上升,中国目前拥有全球最大的糖尿病流行人群。
评估中国成年人群中糖尿病和糖尿病前期的近期患病率,并调查其种族差异。
设计、背景和参与者:2013年在中国大陆开展的一项具有全国代表性的横断面调查,共有170287名参与者。
测量所有参与者的空腹血糖和糖化血红蛋白水平。对所有未诊断为糖尿病的参与者进行口服葡萄糖耐量试验。
主要结局为根据2010年美国糖尿病协会标准定义的糖尿病和糖尿病前期的总体患病率。同时评估知晓率和治疗率。治疗的糖尿病患者糖化血红蛋白浓度低于7.0%被视为血糖控制良好。将中国至少有1000名参与者的少数民族(藏族、壮族、满族、维吾尔族和穆斯林)与汉族参与者进行比较。
在中国成年人群中,估计已诊断和未诊断糖尿病的标准化总体患病率为10.9%(95%CI,10.4%-11.5%);已诊断糖尿病的患病率为4.0%(95%CI,3.6%-4.3%);糖尿病前期的患病率为35.7%(95%CI,34.1%-37.4%)。在糖尿病患者中,36.5%(95%CI,34.3%-38.6%)知晓自己的病情,32.2%(95%CI,30.1%-34.2%)接受了治疗;接受治疗的患者中有49.2%(95%CI,46.9%-51.5%)血糖控制良好。藏族和中国穆斯林的糖尿病粗患病率显著低于汉族参与者(汉族为14.7%[95%CI,14.6%-14.9%],藏族为4.3%[95%CI,3.5%-5.0%],穆斯林为10.6%[95%CI,9.3%-11.9%];藏族和穆斯林与汉族相比,P<0.001)。在多变量逻辑模型中,与汉族参与者相比,藏族中国人患糖尿病的校正比值比为0.42(95%CI,0.35-0.50),患糖尿病前期的校正比值比为0.77(95%CI,0.71-0.84);中国穆斯林患糖尿病的校正比值比为0.73(95%CI,0.63-0.85),患糖尿病前期的校正比值比为0.78(95%CI,0.71-0.86)。
在中国成年人中,估计糖尿病总体患病率为10.9%,糖尿病前期患病率为35.7%。与2010年之前的估计值存在差异可能是由于糖化血红蛋白测量方法不同。